Literature DB >> 30723137

Antibody specificity and promiscuity.

Deepti Jain1, Dinakar M Salunke2.   

Abstract

The immune system is capable of making antibodies against anything that is foreign, yet it does not react against components of self. In that sense, a fundamental requirement of the body's immune defense is specificity. Remarkably, this ability to specifically attack foreign antigens is directed even against antigens that have not been encountered a priori by the immune system. The specificity of an antibody for the foreign antigen evolves through an iterative process of somatic mutations followed by selection. There is, however, accumulating evidence that the antibodies are often functionally promiscuous or multi-specific which can lead to their binding to more than one antigen. An important cause of antibody cross-reactivity is molecular mimicry. Molecular mimicry has been implicated in the generation of autoimmune response. When foreign antigen shares similarity with the component of self, the antibodies generated could result in an autoimmune response. The focus of this review is to capture the contrast between specificity and promiscuity and the structural mechanisms employed by the antibodies to accomplish promiscuity, at the molecular level. The conundrum between the specificity of the immune system for foreign antigens on the one hand and the multi-reactivity of the antibody on the other has been addressed. Antibody specificity in the context of the rapid evolution of the antigenic determinants and molecular mimicry displayed by antigens are also discussed.
© 2019 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Keywords:  antigen–antibody recognition; cross-reactivity; multi-specificity; plasticity

Mesh:

Substances:

Year:  2019        PMID: 30723137     DOI: 10.1042/BCJ20180670

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  7 in total

1.  Guidelines, Strategies, and Principles for the Directed Evolution of Cross-Reactive Antibodies Using Yeast Surface Display Technology.

Authors:  Sara Linciano; Ee Lin Wong; Ylenia Mazzocato; Monica Chinellato; Tiziano Scaravetti; Alberto Caregnato; Veronica Cacco; Zhanna Romanyuk; Alessandro Angelini
Journal:  Methods Mol Biol       Date:  2022

2.  Assessment of Therapeutic Antibody Developability by Combinations of In Vitro and In Silico Methods.

Authors:  Adriana-Michelle Wolf Pérez; Nikolai Lorenzen; Michele Vendruscolo; Pietro Sormanni
Journal:  Methods Mol Biol       Date:  2022

Review 3.  Peptides, Antibodies, Peptide Antibodies and More.

Authors:  Nicole Trier; Paul Hansen; Gunnar Houen
Journal:  Int J Mol Sci       Date:  2019-12-13       Impact factor: 5.923

4.  The biology of ergothioneine, an antioxidant nutraceutical.

Authors:  Irina Borodina; Louise C Kenny; Cathal M McCarthy; Kalaivani Paramasivan; Etheresia Pretorius; Timothy J Roberts; Steven A van der Hoek; Douglas B Kell
Journal:  Nutr Res Rev       Date:  2020-02-13       Impact factor: 7.800

5.  Generation of a Peptide Vaccine Candidate against Falciparum Placental Malaria Based on a Discontinuous Epitope.

Authors:  Catherine J Mitran; Lauren M Higa; Michael F Good; Stephanie K Yanow
Journal:  Vaccines (Basel)       Date:  2020-07-18

6.  Ensembles in solution as a new paradigm for antibody structure prediction and design.

Authors:  Monica L Fernández-Quintero; Guy Georges; Janos M Varga; Klaus R Liedl
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

Review 7.  Immunoaffinity Capillary Electrophoresis in the Era of Proteoforms, Liquid Biopsy and Preventive Medicine: A Potential Impact in the Diagnosis and Monitoring of Disease Progression.

Authors:  Norberto A Guzman; Daniel E Guzman
Journal:  Biomolecules       Date:  2021-10-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.